Evaluation and management of anemia and bleeding disorders in surgical patients

Medical Clinics of North America

Volumn 87, Issue 1, 2003, Pages 229-242

  Armas Loughran, Barbara ^a   Kalra, Rakhi ^a   Carson, Jeffrey L ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 9; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYANOCOBALAMIN; DESMOPRESSIN; ERYTHROPOIETIN; ESTROGEN; FOLIC ACID; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 8; STEROID; VASODILATOR AGENT; VITAMIN K GROUP; VON WILLEBRAND FACTOR;

ANEMIA; BLEEDING DISORDER; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG INDICATION; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; IRON DEFICIENCY ANEMIA; LABORATORY TEST; MAXIMUM ALLOWABLE CONCENTRATION; MEDICAL DECISION MAKING; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; RETICULOCYTE COUNT; REVIEW; SURGICAL MORTALITY; SURGICAL RISK; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT INDICATION; TREATMENT PLANNING; VON WILLEBRAND DISEASE;

ANEMIA; ANIMALS; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; HEMORRHAGIC DISORDERS; HEMOSTASIS, SURGICAL; HUMANS; PERIOPERATIVE CARE; THROMBOCYTOPENIA;

EID: 0037258209     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00154-2     Document Type: Review

References (52)

1. Brecher ME, Zylstra-Halling VW, Pineda AA. Rejuvenation of erythrocytes preserved with AS-1 and AS-3. Am J Clin Pathol 1991;96:767-9.
2. Kennedy AC, Valtis DJ. The oxygen dissociation curve in anemia of various types. J Clin Invest 1954;33:1372-81.
3. Rodman T, Close HP, Purcell MK. The oxyhemoglobin dissociation curve in anemia. Ann Intern Med 1960;52:295-309.
4. Brannon ES, Merrill AJ, Warren VJ, et al. The cardiac output in patients with chronic anemia as measured by the technique of right atrial catheterization. J Clin Invest 1945;24:332-6.
5. Chapler CK, Cain SM. The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol 1985;64:7-12.
6. Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation 1969;39:503-15.
7. Murray JF, Escobar E, Rapaport E. Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia. Am J Physiol 1969;216:638-42.
8. Crystal GJ, Salem MR. Myocardial oxygen consumption and segmental shortening during selective coronary hemodilution in dogs. Anesth Analg 1988;67:500-8.
9. Habler OP, Kleen MS, Podtschaske AH, et al. The effect of acute normovolemic hemodilution (ANH) on myocardial contractility in anesthetized dogs. Anesth Analg 1996; 83:451-8.
10. Spahn DR, Smith LR, Veronee CD, et al. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993;105:694-704.
11. Audet AM, Andrzejewski C, Popovsky MA. Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics 1998; 21:851-8.
12. Churchill WH, Mcgurk S, Chapman RH, et al. The collaborative hospital transfusion study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. Transfusion 1998;38:530-9.
13. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusions in total knee and total hip replacement surgery. Transfusion 1991;31:531-7.
14. Surgenor DM, Churchill WH, Wallace EL, et al. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion 1998;38:122-34.
15. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-60.
16. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion. Transfusion 2002;42(7):812-8.
17. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998;279:199-205.
18. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 1998;116:460-7.
19. Carson JL, Hebert PC. Anemia and red cell transfusion. In: Simon TL, Dizik WH, Snyder E, et al, editors. Rossi's principles of transfusion medicine. 3rd edition. Philadelphia: Lippincott Williams & Wilkins, in press.
20. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999;39:1070-7.
21. Lotke PA, Barth P, Garino JP, et al. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. J Arthroplasty 1999;14: 647-50.
22. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin- level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38:522-9.
23. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators. Canadian Critical Care Trials Group. N Engl J Med 1999;340: 409-17.
24. Wilkerson DK, Rosen AL, Sehgal LR, et al. Limits of cardiac compensation in anemic baboons. Surgery 1988;103:665-70.
25. Hagl S, Heimisch W, Meisner H, et al. The effect of hemodilution on regional myocardial function in the presence of coronary stenosis. Basic Res Cardiol 1977;72:344-64.
26. Yoshikawa H, Powell Jr. WJ, Bland JH, et al. Effect of acute anemia on experimental myocardial ischemia. Am J Cardiol 1973;32:670-8.
27. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-6.
28. Hogue CW, Goodnough LT, Monk TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998;38:924-31.
29. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-6.
30. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995;333: 206-13.
31. Toy PT, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery: a national multicenter study. N Engl J Med 1987;316:517-20.
32. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. Second of two parts-blood conservation [see comments]. N Engl J Med 1999;340:525-33.
33. Linden JV, Kruskall MS. Autologous blood: always safer? Transfusion 1997;37:455-6.
34. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995;35:734-7.
35. Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals: a College of American Pathologists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1992;116:613-9.
36. Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA 1986;256:750-3.
37. Eisenberg JM, Goldfarb S. Clinical usefulness of measuring prothrombin time as a routine admission test. Clin Chem 1976;22:1644-7.
38. Ramsey G, Arvan DA, Stewart S, et al. Do preoperative laboratory tests predict blood transfusion needs in cardiac operations? J Thorac Cardiovasc Surg 1983;85:564-9.
39. Sady S, Sweitzer B. Hematologic issues. In: Swetizer B, editor. Handbook of preoperative assessment and management. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 159-95.
40. Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998;133:134-9.
41. Mannucci PM, Tuddenham EG. The hemophilias: from royal genes to gene therapy. N Engl J Med 2001;344:1773-9.
42. Martlew VJ. Peri-operative management of patients with coagulation disorders. Br J Anaesth 2000;85:446-55.
43. Kaplan EB, Sheiner LB, Boeckmann AJ, et al. The usefulness of preoperative laboratory screening. JAMA 1985;253:3576-81.
44. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-57.
45. Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy [see comments]. Anesthesiology 1996;84:732-47.
46. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972;287:155-9.
47. Yardumian DA, Mackie IJ, Machin SJ. Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 1986;39:701-12.
48. Gralnick HR, Rick ME, McKeown LP, et al. Platelet von Willebrand's factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood 1986;68:58-61.
49. Mannucci PM, Lombardi R, Bader R, et al. Heterogeneity of type I von Willebrand's disease: evidence for a subgroup with an abnormal von Willebrand's factor. Blood 1985;66:796-802.
50. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
51. Livio M, Gotti E, Marchesi D, et al. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 1982;2:1013-5.
52. Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoagulability in uremic patients: a viscoelastic study. J Clin Anesth 1997;9:442-5.